US20100311180A1 - Process for preparation of labisia pumila extract - Google Patents
Process for preparation of labisia pumila extract Download PDFInfo
- Publication number
- US20100311180A1 US20100311180A1 US12/722,621 US72262110A US2010311180A1 US 20100311180 A1 US20100311180 A1 US 20100311180A1 US 72262110 A US72262110 A US 72262110A US 2010311180 A1 US2010311180 A1 US 2010311180A1
- Authority
- US
- United States
- Prior art keywords
- process according
- extract
- water
- labisia pumila
- dried
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- LNTHITQWFMADLM-UHFFFAOYSA-N O=C(O)C1=CC(O)=C(O)C(O)=C1 Chemical compound O=C(O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Definitions
- the present invention relates generally to a process for preparation of plant extract and more particularly to the process for preparation of water-soluble Labisia pumila extract, and to obtain a reproducible chemical profile by reverse-phase high performance liquid chromatography (HPLC).
- HPLC reverse-phase high performance liquid chromatography
- Kacip fatimah or Selusoh fatimah, Rumput siti fatimah, Akar fatimah, Kachit fatimah, Kachip Fatima, Kachip patima, Kunchi fatimah, Pokok pinggang, Rumput palis, Tadah mata hari, Mata pelandok rimba, Bunga belangkas hutan), as disclosed in Burkhill (1993) is used much in childbirth.
- a decoction of the plant is given not only after childbirth as a protective medicine, but before to expedite labour. Additional uses include being given for flatulence, dysentery, dysmenorrhoea, gonorrhoea and “sickness in the bones”.
- a process for preparation of Labisia pumila extract by extracting dried Labisia pumila material with water to form a water-soluble extract and drying the extract obtained, characterized in that the ratio of dried Labisia pumila plant material:water is 1:6.
- a process for obtaining optimized and reproducible chemical profile of Labisia pumila extract comprising the steps of:
- the present invention relates to a process for the preparation of a water-soluble Labisia pumila extract from Labisia pumila plant material.
- the solvent used in the process of the present invention is water.
- FIG. 1 shows a typical chromatogram of the Labisia pumila reverse-phase HPLC profile.
- the asterisk (*) indicates the marker compound.
- the present invention relates to a process for preparation of a water-soluble Labisia pumila extract from Labisia pumila plant material and to obtain an optimized and reproducible chemical profile by reverse-phase high performance liquid chromatography.
- the present invention which is a process for preparation of a water-soluble Labisia pumila extract comprises the following steps (1)-(4):
- Step 1 extracting Labisia pumila dried plant material with a solvent (water) to form a water-soluble extract and concentrating the extract to dryness;
- Step 2 subjecting the dried concentrated water-soluble Labisia pumila extract to reverse-phase high performance liquid chromatography (HPLC) analysis to obtain an optimized and reproducible chemical profile;
- HPLC high performance liquid chromatography
- Step 3 isolating a marker compound from the water-soluble Labisia pumila extract by chromatographic method consisting of reverse-phase high performance liquid chromatography (HPLC); and
- Step 4 elucidating the structure of the marker compound obtained from the water-soluble Labisia pumila extract by nuclear magnetic resonance (nmr) spectrometry, liquid chromatography mass spectrometry (lcms) and ultraviolet (uv) spectrometry.
- the process for preparation of a water-soluble Labisia pumila extract described the method for obtaining a water-soluble Labisia pumila extract by extracting Labisia pumila dried plant material with a solvent (water) to form a water-soluble extract and concentrating the extract to dryness; and subjecting the dried concentrated water-soluble Labisia pumila extract to reverse-phase high performance liquid chromatography (HPLC) analysis to obtain an optimized and reproducible chemical profile.
- HPLC high performance liquid chromatography
- the process also follows a time-tested process of preparing Labisia pumila extract by traditional Malay medicine practitioners, albeit, on a smaller scale, for individual consumption.
- the process of the present invention can therefore yield the desired extract that is free from introduced chemical impurities and is reproducible.
- the starting material In the process for the preparation of water-soluble Labisia pumila extract according to the present invention, the starting material must be Labisia pumila plant material. In the present invention, only Labisia pumila plant material may be used as the starting material.
- the starting material is fully dehydrated by drying at 40° C. for 3 days before use so that it will not be affected by the polarity of a solvent.
- the above-described starting material may be used as the starting material in the present invention in any form, for example, solid powder, or minced form, or even in the form of any combination of these forms.
- a conventional method is used to prepare a water-soluble Labisia pumila extract.
- a solvent typically used for this solvent extraction method is a non-polar solvent.
- water a polar solvent
- it has been used as an extraction solvent in the food industry, and is thus highly safe.
- the method for extracting Labisia pumila is effected by means of extraction at approximately 80° C., in order to attain increased efficiency of extraction. This extraction is conducted over a period of 3 hours and with continuous stirring. This extraction is repeated with an equal volume of fresh solvent, i.e., a two-stage process, in the ratio of one part dried plant material and six parts water.
- a conventional method is used to dry the extract that has been obtained from the starting material to dryness.
- Typical examples of methods of concentration include concentration under reduced pressure, concentration by heating, through-flow concentration, freeze concentration, and spray concentration, and these methods may be used either singly or in combination.
- spray-drying is preferably used.
- the tower inlet and outlet temperatures are set at 185° C. and 107° C., respectively. It is a simple and inexpensive method for removing the solvent that has been used for drying the extracted starting material.
- 100 kg of Labisia pumila dried and ground plant material is subjected to extraction by heating in 600 L of water at 80° C. over a period of 3 hours and with continuous stirring.
- the solvent is replaced with an equal volume of fresh solvent at the end of the extracting period and the plant material re-extracted.
- the mixtures are pooled together, then filtered and filtrate subjected to spray drying.
- the spray tower conditions are as follows; tower inlet and outlet temperatures are set at 185° C. and 107° C., respectively.
- the yield of water-soluble extract powder is 4-5%.
- 150 kg of Labisia pumila dried and ground plant material is subjected to extraction by heating in 900 L of water at 80° C. over a period of 6 hours and with continuous stirring.
- the solvent is replaced with an equal volume of fresh solvent at the end of the extracting period and the plant material re-extracted.
- the mixtures are pooled together, then filtered and filtrate subjected to spray drying.
- the spray tower conditions are as follows; tower inlet and outlet temperatures are set at 185° C. and 107° C., respectively.
- the yield of water-soluble extract powder is 4-5%.
- a conventional method is used to profile the extract which is water-soluble, chemically.
- reverse-phase high performance liquid chromatography HPLC
- a conventional detector for example, an ultraviolet, diode array or photodiode array detector (wavelength set at 254 nm) can be used for detection.
- the dried extract is accurately weighed and approximately 35-45 mg and centrifuged in exactly 10 ml of water at 20,000 rpm and room temperature for 15 minutes. Upon completion, the supernatant is transferred into a 10-mL volumetric flask, diluted to the mark with water, shaken for 15 minutes and then filtered with a 0.45 ⁇ m PTFE membrane filter.
- a reference solution is also prepared in a similar manner.
- the solution is further serially diluted and used to construct a three or five point calibration curve.
- HPLC high performance liquid chromatography
- FIG. 1 A typical chromatogram of the Labisia pumila reverse-phase HPLC profile is shown in FIG. 1 .
- the asterisk (*) indicates the marker compound.
- the chemical compound used as a marker for the extract typically appears as a single peak absorbing at 254 nm between 15 to 17 minutes in the HPLC profile or chromatogram.
- the chemical compound used as a marker is typically 35-45 ⁇ g/ml as quantified by HPLC.
- the marker compound analyzed and quantified from the water-soluble Labisia pumila extract was isolated, structurally elucidated and identified by means of 10 comparison with-a known standard reference.
- a conventional method used to isolate the marker compound from the water-soluble Labisia pumila extract by chromatographic method consists of semi-preparative or preparative reverse-phase high performance liquid chromatography (HPLC).
- HPLC high performance liquid chromatography
- the marker compound is collected as a pure fraction at retention times between 15 minutes to 17 minutes.
- the marker compound dried in vacuum is a brown powder, sparingly soluble in hydrophilic solvents
- elucidating the structure of the marker compound involves nuclear magnetic resonance (nmr) spectrometry, liquid chromatography mass spectrometry (lcms) and ultraviolet (uv) spectrophotometry.
- nmr nuclear magnetic resonance
- lcms liquid chromatography mass spectrometry
- uv ultraviolet spectrophotometry
- the marker compound will give an M-1 ion at m/z 169.2 using negative ion APCI in liquid chromatography mass spectrometry (lcms), thus indicating a molecular weight of 170 which is compatible with the empirical formula C 7 H 6 O 5 .
- Ions at 168 and 125 are indicative of the loss of H and COOH and suggest the presence of a carboxylic acid.
- the marker compound will give a single maximum at approximately 270 nm in ultraviolet (uv), suggesting a simple aromatic ring.
- the marker compound run in nuclear magnetic resonance (nmr) using deuterated dimethyl sulfoxide (DMSO-d 6 ) as solvent gives a proton (1H) spectrum with the following resonances; a single signal for proton(s) bonded to carbon at ⁇ 6.92 and broad signals between ⁇ 9 and ⁇ 10 attributed to protons attached to oxygen.
- DMSO-d 6 deuterated dimethyl sulfoxide
- the marker compound run in nuclear magnetic resonance using deuterated dimethyl sulfoxide (DMSO-d 6 ) as solvent gives a carbon ( 13 C) spectrum with the following resonances; ⁇ 167.4 (1C, carboxylic acid), 145.4 (2C, aromatic carbons attached to oxygen and with an oxygen on an adjacent carbon), 138.0 (1C, aromatic carbon attached to oxygen and with oxygens also attached to both adjacent carbons), 120.4 (aromatic carbon), 108.7 (2C, methine (CH) aromatic carbons).
- the doubling of resonances at ⁇ 145.4 and 108.7 required the molecule to be symmetrical and that the resonances at ⁇ 145.4 and 138.0 required three adjacent aromatic carbons be oxygenated.
- highly concentrated herbal extracts especially of Labisia pumila
- starting material consisting of Labisia pumila
- the Labisia pumila extract obtained by the process of the present invention can be supplied in large quantities as starting material for the medicinal, pharmaceutical and food industries, in which the supply of Labisia pumila is now in high demand.
- the Labisia pumila obtained by the process of the present invention can be used as starting material for producing individual pharmacologically active chemical compounds in the future.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pregnancy & Childbirth (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Extraction Or Liquid Replacement (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
A process for the preparation of Labisia pumila extract from Labisia pumila plant material and to obtain an optimized and reproducible chemical profile by high performance liquid chromatography.
Description
- This application is a divisional of U.S. patent application Ser. No. 11/330,701, filed Jan. 12, 2006, which is incorporated by reference herein in its entirety.
- The present invention relates generally to a process for preparation of plant extract and more particularly to the process for preparation of water-soluble Labisia pumila extract, and to obtain a reproducible chemical profile by reverse-phase high performance liquid chromatography (HPLC).
- Traditional Malay medicine dictates that “kacip fatimah” (or Selusoh fatimah, Rumput siti fatimah, Akar fatimah, Kachit fatimah, Kachip Fatima, Kachip patima, Kunchi fatimah, Pokok pinggang, Rumput palis, Tadah mata hari, Mata pelandok rimba, Bunga belangkas hutan), as disclosed in Burkhill (1993) is used much in childbirth. A decoction of the plant is given not only after childbirth as a protective medicine, but before to expedite labour. Additional uses include being given for flatulence, dysentery, dysmenorrhoea, gonorrhoea and “sickness in the bones”.
- While there is now an increasing demand for the supply of “kacip fatimah” (Labisia pumila syn. Labisia pothoina) in the food industries, the reproducibility of extraction processes is still in doubt due to the lack of reliable chemical profiling methods.
- Accordingly, it is the primary object of the present invention to provide a process for the preparation of a water-soluble Labisia pumila extract from Labisia pumila plant material.
- It is another object of the present invention to provide a method for isolating a marker compound from water-soluble Labisia pumila extract by reverse-phase high performance liquid chromatography (HPLC).
- It is yet another object of the present invention to provide structural elucidation of the marker compound obtained from the water-soluble Labisia pumila extract by nuclear magnetic resonance (nmr) spectrometry, liquid chromatography mass spectrometry (lcms) and ultraviolet (uv) spectrophotometry.
- These and other objects of the present invention are accomplished by providing,
- A process for preparation of Labisia pumila extract by extracting dried Labisia pumila material with water to form a water-soluble extract and drying the extract obtained, characterized in that the ratio of dried Labisia pumila plant material:water is 1:6.
- and
- A process for obtaining optimized and reproducible chemical profile of Labisia pumila extract comprising the steps of:
- a) centrifuging a mixture of water and dried extract obtained by extracting dried Labisia pumila plant material with water in a ratio of 1:6 of dried Labisia pumila plant material:water to form a water-soluble extract and drying the extract; optionally drying at a temperature of 40° C. for 3 days; optionally wherein the extraction process is carried out at 80° C. for 3 hours and with continuous stirring; optionally wherein the extraction process is repeated and the ratio of Labisia pumila plant material:water is 1:6; optionally wherein the Labisia pumila extract is dried and concentrated by spray-drying; optionally wherein the spray-drying is performed using a spray tower having a tower inlet and outlet, and wherein tower inlet temperature is 185° C. and wherein tower outlet temperature is 107° C., respectively;
- b) diluting the supernatant obtained from (a) to 10 ml, with shaking;
- c) filtering the diluted supernatant obtained in (b) with a 0.45 μm PTFE membrane filter; and d) subjecting the filtered supernatant obtained in (c) to high performance liquid chromatography analysis.
- and
- A process for isolating a marker compound by semi-preparative reverse-phase high performance liquid chromatography from Labisia pumila extract obtained by extracting dried Labisia pumila plant material with water in a ratio of 1:6 of dried Labisia pumila plant material:water to form a water-soluble extract and drying the extract; optionally drying at a temperature of 40° C. for 3 days; optionally wherein the extraction process is carried out at 80° C. for 3 hours and with continuous stirring; optionally wherein the extraction process is repeated and the ratio of Labisia pumila plant material:water is 1:6; optionally wherein the Labisia pumila extract is dried and concentrated by spray-drying; optionally wherein the spray-drying is performed using a spray tower having a tower inlet and outlet, and wherein tower inlet temperature is 185° C. and wherein tower outlet temperature is 107° C., respectively.
- and
- A process for elucidating the structure of a marker compound by any one of nuclear magnetic resonance spectrometry, liquid chromatography mass spectrometry and ultraviolet spectrophotometry from Labisia pumila extract obtained by extracting dried Labisia pumila plant material with water in a ratio of 1:6 of dried Labisia pumila plant material:water to form a water-soluble extract and drying the extract; optionally drying at a temperature of 40° C. for 3 days; optionally wherein the extraction process is carried out at 80° C. for 3 hours and with continuous stirring; optionally wherein the extraction process is repeated and the ratio of Labisia pumila plant material:water is 1:6; optionally wherein the Labisia pumila extract is dried and concentrated by spray-drying; optionally wherein the spray-drying is performed using a spray tower having a tower inlet and outlet, and wherein tower inlet temperature is 185° C. and wherein tower outlet temperature is 107° C., respectively.
- The present invention relates to a process for the preparation of a water-soluble Labisia pumila extract from Labisia pumila plant material. When considering the potential utilization of Labisia pumila in food products, medicines, etc., the safety of its use is considered as the solvent used in the process of the present invention is water.
-
FIG. 1 shows a typical chromatogram of the Labisia pumila reverse-phase HPLC profile. The asterisk (*) indicates the marker compound. - The present invention relates to a process for preparation of a water-soluble Labisia pumila extract from Labisia pumila plant material and to obtain an optimized and reproducible chemical profile by reverse-phase high performance liquid chromatography.
- Typically, the present invention which is a process for preparation of a water-soluble Labisia pumila extract comprises the following steps (1)-(4):
- Step 1: extracting Labisia pumila dried plant material with a solvent (water) to form a water-soluble extract and concentrating the extract to dryness;
- Step 2: subjecting the dried concentrated water-soluble Labisia pumila extract to reverse-phase high performance liquid chromatography (HPLC) analysis to obtain an optimized and reproducible chemical profile;
- Step 3: isolating a marker compound from the water-soluble Labisia pumila extract by chromatographic method consisting of reverse-phase high performance liquid chromatography (HPLC); and
- Step 4: elucidating the structure of the marker compound obtained from the water-soluble Labisia pumila extract by nuclear magnetic resonance (nmr) spectrometry, liquid chromatography mass spectrometry (lcms) and ultraviolet (uv) spectrometry.
- As mentioned above, the process for preparation of a water-soluble Labisia pumila extract according to the present invention, described the method for obtaining a water-soluble Labisia pumila extract by extracting Labisia pumila dried plant material with a solvent (water) to form a water-soluble extract and concentrating the extract to dryness; and subjecting the dried concentrated water-soluble Labisia pumila extract to reverse-phase high performance liquid chromatography (HPLC) analysis to obtain an optimized and reproducible chemical profile. By utilizing this process it is possible to successfully provide a process for preparing water-soluble Labisia pumila extract that is consistently reproducible.
- The process also follows a time-tested process of preparing Labisia pumila extract by traditional Malay medicine practitioners, albeit, on a smaller scale, for individual consumption. The process of the present invention can therefore yield the desired extract that is free from introduced chemical impurities and is reproducible.
- Process for Preparation of Water-Soluble Labisia pumila Extract
- In the process for the preparation of water-soluble Labisia pumila extract according to the present invention, the starting material must be Labisia pumila plant material. In the present invention, only Labisia pumila plant material may be used as the starting material.
- The starting material is fully dehydrated by drying at 40° C. for 3 days before use so that it will not be affected by the polarity of a solvent.
- The above-described starting material may be used as the starting material in the present invention in any form, for example, solid powder, or minced form, or even in the form of any combination of these forms.
- A conventional method is used to prepare a water-soluble Labisia pumila extract. In the present invention, it is preferable to use a solvent extraction method, which is most frequently used these days.
- Using the solvent extraction method, it is possible to fully extract Labisia pumila, which is necessary in the process of the invention.
- A solvent typically used for this solvent extraction method is a non-polar solvent. In the present invention, water (a polar solvent) is used to adhere to a time-tested traditional Malay practice of extracting Labisia pumila. Moreover, it has been used as an extraction solvent in the food industry, and is thus highly safe.
- The method for extracting Labisia pumila is effected by means of extraction at approximately 80° C., in order to attain increased efficiency of extraction. This extraction is conducted over a period of 3 hours and with continuous stirring. This extraction is repeated with an equal volume of fresh solvent, i.e., a two-stage process, in the ratio of one part dried plant material and six parts water.
- A conventional method is used to dry the extract that has been obtained from the starting material to dryness.
- Typical examples of methods of concentration include concentration under reduced pressure, concentration by heating, through-flow concentration, freeze concentration, and spray concentration, and these methods may be used either singly or in combination. In the present invention, spray-drying is preferably used. The tower inlet and outlet temperatures are set at 185° C. and 107° C., respectively. It is a simple and inexpensive method for removing the solvent that has been used for drying the extracted starting material.
- In one embodiment, 100 kg of Labisia pumila dried and ground plant material is subjected to extraction by heating in 600 L of water at 80° C. over a period of 3 hours and with continuous stirring. The solvent is replaced with an equal volume of fresh solvent at the end of the extracting period and the plant material re-extracted. The mixtures are pooled together, then filtered and filtrate subjected to spray drying. The spray tower conditions are as follows; tower inlet and outlet temperatures are set at 185° C. and 107° C., respectively. The yield of water-soluble extract powder is 4-5%.
- In another embodiment, 150 kg of Labisia pumila dried and ground plant material is subjected to extraction by heating in 900 L of water at 80° C. over a period of 6 hours and with continuous stirring. The solvent is replaced with an equal volume of fresh solvent at the end of the extracting period and the plant material re-extracted. The mixtures are pooled together, then filtered and filtrate subjected to spray drying. The spray tower conditions are as follows; tower inlet and outlet temperatures are set at 185° C. and 107° C., respectively. The yield of water-soluble extract powder is 4-5%.
- A conventional method is used to profile the extract which is water-soluble, chemically.
- In the present invention, reverse-phase high performance liquid chromatography (HPLC) is typically used, and a conventional detector, for example, an ultraviolet, diode array or photodiode array detector (wavelength set at 254 nm) can be used for detection.
- By conducting reverse-phase high performance liquid chromatography, it is possible to chemically profile the water-soluble extract. In the present invention, the chemical profiling method used is reproducible.
- Typically, to prepare a sample for chemical profiling, the dried extract is accurately weighed and approximately 35-45 mg and centrifuged in exactly 10 ml of water at 20,000 rpm and room temperature for 15 minutes. Upon completion, the supernatant is transferred into a 10-mL volumetric flask, diluted to the mark with water, shaken for 15 minutes and then filtered with a 0.45 μm PTFE membrane filter.
- Typically, a reference solution is also prepared in a similar manner. The solution is further serially diluted and used to construct a three or five point calibration curve.
- High performance liquid chromatography (HPLC) system parameters are set as below:
-
Column stationary phase: octadecylsilyl silica gel for reverse-phase chromatography 250 mm × 4.6 mm, 120 Å dp - 4 μm Mobile Phase A = CH3CN; B = H2O (0.25% H3PO4) Solvent System A/B = 1/99 Flow Rate 1 ml/min Temperature Ambient Wavelength 254 nm Sample Size 50 μL - A typical chromatogram of the Labisia pumila reverse-phase HPLC profile is shown in
FIG. 1 . The asterisk (*) indicates the marker compound. - The chemical compound used as a marker for the extract typically appears as a single peak absorbing at 254 nm between 15 to 17 minutes in the HPLC profile or chromatogram.
- The chemical compound used as a marker is typically 35-45 μg/ml as quantified by HPLC.
- The marker compound analyzed and quantified from the water-soluble Labisia pumila extract was isolated, structurally elucidated and identified by means of 10 comparison with-a known standard reference.
- A conventional method used to isolate the marker compound from the water-soluble Labisia pumila extract by chromatographic method consists of semi-preparative or preparative reverse-phase high performance liquid chromatography (HPLC).
- High performance liquid chromatography (HPLC) system parameters are set as below:
-
Solvent System Isocratic, 99% (0.1% H3PO4):1% (CH3CN) Temperature Ambient Wavelength Detection 254 nm - Typically, the marker compound is collected as a pure fraction at retention times between 15 minutes to 17 minutes.
- Typically, the marker compound dried in vacuum is a brown powder, sparingly soluble in hydrophilic solvents
- Typically, elucidating the structure of the marker compound involves nuclear magnetic resonance (nmr) spectrometry, liquid chromatography mass spectrometry (lcms) and ultraviolet (uv) spectrophotometry.
- Typically the marker compound will give an M-1 ion at m/z 169.2 using negative ion APCI in liquid chromatography mass spectrometry (lcms), thus indicating a molecular weight of 170 which is compatible with the empirical formula C7H6O5. Ions at 168 and 125 are indicative of the loss of H and COOH and suggest the presence of a carboxylic acid.
- Typically the marker compound will give a single maximum at approximately 270 nm in ultraviolet (uv), suggesting a simple aromatic ring.
- Typically the marker compound run in nuclear magnetic resonance (nmr) using deuterated dimethyl sulfoxide (DMSO-d6) as solvent gives a proton (1H) spectrum with the following resonances; a single signal for proton(s) bonded to carbon at δ 6.92 and broad signals between δ 9 and δ 10 attributed to protons attached to oxygen.
- Typically the marker compound run in nuclear magnetic resonance using deuterated dimethyl sulfoxide (DMSO-d6) as solvent gives a carbon (13C) spectrum with the following resonances; δ 167.4 (1C, carboxylic acid), 145.4 (2C, aromatic carbons attached to oxygen and with an oxygen on an adjacent carbon), 138.0 (1C, aromatic carbon attached to oxygen and with oxygens also attached to both adjacent carbons), 120.4 (aromatic carbon), 108.7 (2C, methine (CH) aromatic carbons). Also typically, the doubling of resonances at δ 145.4 and 108.7 required the molecule to be symmetrical and that the resonances at δ 145.4 and 138.0 required three adjacent aromatic carbons be oxygenated.
- The identity of the marker compound isolated and structurally elucidated, was further verified by means of comparison with a known standard reference. As such the structure of the compound is determined to be 3,4,5-trihydroxybenzoic acid, as follows:
- Thus, by using the process as described in the present invention, highly concentrated herbal extracts, especially of Labisia pumila, can be obtained easily and inexpensively from starting material consisting of Labisia pumila. The Labisia pumila extract obtained by the process of the present invention can be supplied in large quantities as starting material for the medicinal, pharmaceutical and food industries, in which the supply of Labisia pumila is now in high demand. Further, the Labisia pumila obtained by the process of the present invention can be used as starting material for producing individual pharmacologically active chemical compounds in the future.
- Although the present invention has been described above with respect to various presently preferred embodiments, it will be apparent to one of ordinary skill in the art that many variations and modifications may be made. Therefore, the invention is not to be understood as limited to the particular embodiments recited herein but, rather, is to be understood as embracing all such variations and modifications which fall within the spirit and scope of the claims appended hereto.
- All references disclosed herein are incorporated by reference in their entirety.
-
- Burkill, I H 1993. A Dictionary of the Economic Products of the Malay Peninsula. V. II (1-Z). Third print. Kuala Lumpur: Ministry of Agriculture. 1311.
- Indu Bala Jaganath and Lean Teik Ng. 1999. Herbs: The Green Pharmacy of 5 Malaysia. Kuala Lumpur: MARDI and FRIM. 53-54.
- Jamia A. Jamal, Peter J. Houghton and Stuart R. Milligan. 1999. Kacip Fatimah: A Malay Traditional Herb for Pregnant Women. In Phytochemicals and Biopharmaceutins from the Malaysian Rain Forest (A. Manaf Ali, Khozirah Shaari and Zuriati Zakaria, eds.). Kepong: FRIM. 166-176.
- Malaysian Herbal Monograph. Vol. I. Kuala Lumpur: Malaysian Herbal Monograph Committee. 45-48.
- Norhayati Ismail, Muzlifah Abd. Manaf and Zhari Ismail. Pharmacognosical Characterization of Labisia pothoina. In Trends in Traditional Medicine Research (Chan Kit Lam, Abas Hj. Hussin, Amirin Sadikun, Kah Hay Yuen, Mohd. Zaini Asmawi and Zhari Ismail, eds.). Pulau Pinang: Universiti Sains Malaysia. 574-582.
- Benjamin C. Stone. 1988. Notes on the Genus Labisia. Lindl. (Myrsinaceae). Malayan Nature Journal. 42: 43-51.
Claims (34)
1. A process for obtaining optimized and reproducible chemical profile of Labisia pumila extract comprising the steps of:
a) centrifuging a mixture of water and dried extract obtained by extracting dried Labisia pumila plant material with water in a ratio of 1:6 of dried Labisia pumila plant material:water to form a water-soluble extract and drying the extract obtained;
b) diluting the supernatant obtained from (a) to 10 ml, with shaking;
c) filtering the diluted supernatant obtained in (b) with a 0.45 pm PTFE membrane filter;
d) subjecting the filtered supernatant obtained in (c) to high performance liquid chromatography analysis; and
e) obtaining a high performance liquid chromatography profile which contains the marker compound.
2. The process according to claim 1 , wherein the dried Labisia pumila plant material in (a) is prepared by drying at a temperature of 40° C. for 3 days.
3. The process according to claim 1 , wherein the extracting in (a) is carried out at 80° C. for 3 hours and with continuous stirring.
4. The process according to claim 3 , wherein the extracting is repeated and the ratio of Labisia pumila plant material:water is 1:6.
5. The process according to claim 1 , wherein the Labisia pumila extract in (a) is dried and concentrated by spray-drying.
6. The process according to claim 5 , wherein the spray-drying is performed using a spray tower having a tower inlet and outlet, and wherein tower inlet temperature of the tower inlet and outlet are is 185° C. and wherein tower outlet temperature is 107° C., respectively.
7. The process according to claim 1 , a consistent yield of water-soluble extract powder of 4-5% is obtained.
8. The process according to claim 1 , wherein 50-60 mg dried extract in 10 ml water is centrifuged at 20,000 rpm for 15 mins. at room temperature.
9. The process according to claim 1 , wherein the marker compound obtained is 3,4,5-trihydroxybenzoic acid.
10. The process according to claim 9 , wherein the marker compound 3,4,5-trihydroxybenzoic acid appears as a single peak absorbing at 254 nm between 15 to 17 minutes in the high performance liquid chromatography or chromatogram.
11. The process according to claim 9 , wherein the standardized extract contains 35 to 45 μg/ml of the marker compound 3,4,5-trihydroxybenzoic acid.
12. A process for isolating a marker compound from Labisia pumila extract comprising
subjecting the extract to semi-preparative or preparative reverse-phase high performance liquid chromatography,
wherein the extract is obtained by extracting dried Labisia pumila plant material with water in a ratio of 1:6 of dried Labisia pumila plant material:water to form a water-soluble extract and drying the extract obtained.
13. The process according to claim 12 , wherein the dried Labisia pumila plant material is prepared by drying at a temperature of 40° C. for 3 days.
14. The process according to claim 12 , wherein the extracting is carried out at 80° C. for 3 hours and with continuous stirring.
15. The process according to claim 14 , wherein the extracting is repeated and the ratio of Labisia pumila plant material:water is 1:6.
16. The process according to claim 12 , wherein the Labisia pumila extract is dried and concentrated by spray-drying.
17. The process according to claim 16 , wherein the spray-drying is performed using a spray tower having a tower inlet and outlet, and wherein tower inlet temperature of the tower inlet and outlet are is 185° C. and wherein tower outlet temperature is 107° C., respectively.
18. The process according to claim 12 , wherein a consistent yield of water-soluble extract powder of 4-5% is obtained.
19. The process according to claim 12 , wherein reverse-phase high performance liquid chromatography is run at ambient temperature at 254 nm wavelength using 99% (0.1% H3PO4): 1% (CH3Cl) as a solvent in an isocratic system.
20. The process according to claim 12 , wherein the marker compound obtained is 3,4,5-trihydroxybenzoic acid.
21. The process according to claim 20 , wherein the marker compound 3,4,5-trihydroxybenzoic acid appears as a single peak absorbing at 254 nm between 15 to 17 minutes in the high performance liquid chromatography or chromatogram.
22. The process according to claim 20 , wherein the standardized extract contains 35 to 45 μg/ml of the marker compound 3,4,5-trihydroxybenzoic acid.
23. A process for elucidating the structure of a marker compound from Labisia pumila extract comprising
subjecting the isolated marker compound 3,4,5-trihydroxybenzoic acid to any one of the following methods: nuclear magnetic resonance spectrometry, liquid chromatography mass spectrometry and ultraviolet spectrophotometry,
wherein the marker compound 3,4,5-trihydroxybenzoic acid is isolated from the extract obtained by extracting dried Labisia pumila plant material with water in a ratio of 1:6 of dried Labisia pumila plant material:water to form a water-soluble extract and drying the extract obtained.
24. The process according to claim 23 , wherein the dried Labisia pumila plant material is prepared by drying at a temperature of 40° C. for 3 days.
25. The process according to claim 23 , wherein the extracting is carried out at 80° C. for 3 hours and with continuous stirring.
26. The process according to claim 25 , wherein the extracting is repeated and the ratio of Labisia pumila plant material:water is 1:6.
27. The process according to claim 23 , wherein the Labisia pumila extract is dried and concentrated by spray-drying.
28. The process according to claim 27 , wherein the spray-drying is performed using a spray tower having a tower inlet and outlet, and wherein tower inlet temperature of the tower inlet and outlet are is 185° C. and wherein tower outlet temperature is 107° C., respectively.
29. The process according to claim 23 , wherein a consistent yield of water-soluble extract powder of 4-5% is obtained.
30. The process according to claim 23 , wherein nuclear magnetic resonance spectrometry is run using deuterated dimethyl sulfoxide (DMSO-d6) as solvent.
31. The process according to claim 23 , wherein the marker compound obtained is 3,4,5-trihydroxybenzoic acid.
32. The process according to claim 31 , wherein the marker compound 3,4,5-trihydroxybenzoic acid appears as a single peak absorbing at 254 nm between 15 to 17 minutes in the high performance liquid chromatography or chromatogram.
33. The process according to claim 31 , wherein the standardized extract contains 35 to 45 μg/ml of the marker compound 3,4,5-trihydroxybenzoic acid.
34. An optimized and reproducible chemical profile of Labisia pumila extract according to claim 1 wherein the marker compound obtained is 3,4,5-trihydroxybenzoic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/722,621 US20100311180A1 (en) | 2005-10-12 | 2010-03-12 | Process for preparation of labisia pumila extract |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20054784A MY147497A (en) | 2005-10-12 | 2005-10-12 | Process for preparation of labisia pumila extract |
| MYPI20054784 | 2005-10-12 | ||
| US11/330,701 US7879368B2 (en) | 2005-10-12 | 2006-01-12 | Process for preparation of Labisia pumila extract |
| US12/722,621 US20100311180A1 (en) | 2005-10-12 | 2010-03-12 | Process for preparation of labisia pumila extract |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/330,701 Division US7879368B2 (en) | 2005-10-12 | 2006-01-12 | Process for preparation of Labisia pumila extract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20100311180A1 true US20100311180A1 (en) | 2010-12-09 |
Family
ID=37911291
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/330,701 Expired - Fee Related US7879368B2 (en) | 2005-10-12 | 2006-01-12 | Process for preparation of Labisia pumila extract |
| US12/722,621 Abandoned US20100311180A1 (en) | 2005-10-12 | 2010-03-12 | Process for preparation of labisia pumila extract |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/330,701 Expired - Fee Related US7879368B2 (en) | 2005-10-12 | 2006-01-12 | Process for preparation of Labisia pumila extract |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US7879368B2 (en) |
| JP (1) | JP2007106743A (en) |
| CN (1) | CN1947764A (en) |
| MY (1) | MY147497A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013112040A1 (en) | 2012-01-27 | 2013-08-01 | Biotropics Malaysia Berhad | Use of certain trioxygenated benzene derivatives in body fat management |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY147497A (en) * | 2005-10-12 | 2012-12-14 | Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia | Process for preparation of labisia pumila extract |
| US20100303933A1 (en) * | 2007-11-15 | 2010-12-02 | Holista Biotech Sdn. Bhd. | Immunopotentiating composition from labisia pumila extract |
| WO2009064156A1 (en) * | 2007-11-15 | 2009-05-22 | Holista Biotechnology Sdn Bhd | Novel composition obtained from labisia pumila extract for hepatoprotective activity |
| MY151834A (en) * | 2008-03-19 | 2014-07-14 | Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia | A standardised aqueous extract of labisia pumila |
| US8164153B2 (en) * | 2009-05-27 | 2012-04-24 | Continental Automotive Systems, Inc. | Thin semiconductor device having embedded die support and methods of making the same |
| WO2010147449A1 (en) * | 2009-06-16 | 2010-12-23 | Holista Biotech Sdn. Bhd. | Adaptogenic activity of labisia pumila extract |
| MY156604A (en) * | 2012-02-10 | 2016-03-15 | Pharmaniaga Berhad | Optimized extraction process for obtaining labisia pumila extract |
| WO2016093692A1 (en) * | 2014-12-08 | 2016-06-16 | Universiti Sains Malaysia | Standardised extract of labisia pumila for weight reduction and nanoformulation thereof |
| TWI717757B (en) * | 2019-06-14 | 2021-02-01 | 科鼎國際有限公司 | Use of composition containing labisia pumila var. alata extracts in improving acute hemorrhagic anemia |
| US12403166B2 (en) | 2021-11-02 | 2025-09-02 | Medika Natura Sdn. Bhd. | Labisia pumila extract composition and its pharmaceutical formulation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030203050A1 (en) * | 2001-11-29 | 2003-10-30 | Bob Sherwood | Process for co-spray drying liquid herbal extracts with dry silicified MCC |
| US20070082069A1 (en) * | 2005-10-12 | 2007-04-12 | Gov't Of Malaysia, As Rep. By The Ministry Of Science, Technology And Innovation | Process for preparation of labisia pumila extract |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1149690A (en) * | 1997-07-30 | 1999-02-23 | Fuji Sangyo Kk | Composition for stimulating lipolysis |
| WO2004096249A1 (en) * | 2003-04-29 | 2004-11-11 | Li Min Pharmaceutical Factory Of Livzon Pharmaceutical | A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| EP1658879B1 (en) * | 2003-08-28 | 2013-02-20 | Tasly Pharmaceutical Group Co., Ltd. | Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases |
-
2005
- 2005-10-12 MY MYPI20054784A patent/MY147497A/en unknown
-
2006
- 2006-01-12 US US11/330,701 patent/US7879368B2/en not_active Expired - Fee Related
- 2006-03-10 JP JP2006065705A patent/JP2007106743A/en active Pending
- 2006-03-24 CN CNA2006100658100A patent/CN1947764A/en active Pending
-
2010
- 2010-03-12 US US12/722,621 patent/US20100311180A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030203050A1 (en) * | 2001-11-29 | 2003-10-30 | Bob Sherwood | Process for co-spray drying liquid herbal extracts with dry silicified MCC |
| US20070082069A1 (en) * | 2005-10-12 | 2007-04-12 | Gov't Of Malaysia, As Rep. By The Ministry Of Science, Technology And Innovation | Process for preparation of labisia pumila extract |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013112040A1 (en) | 2012-01-27 | 2013-08-01 | Biotropics Malaysia Berhad | Use of certain trioxygenated benzene derivatives in body fat management |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1947764A (en) | 2007-04-18 |
| JP2007106743A (en) | 2007-04-26 |
| MY147497A (en) | 2012-12-14 |
| US7879368B2 (en) | 2011-02-01 |
| US20070082069A1 (en) | 2007-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100311180A1 (en) | Process for preparation of labisia pumila extract | |
| Walker | HPLC analysis of selected xanthones in mangosteen fruit | |
| CN109369344A (en) | A method for separating and extracting cannabidiol from industrial hemp plants | |
| Assimopoulou et al. | Analysis of alkannin derivatives from Alkanna species by high‐performance liquid chromatography/photodiode array/mass spectrometry | |
| Milevskaya et al. | Extraction and determination of biologically active components of St. John’s wort and its pharmaceutical preparations | |
| CN107505405A (en) | The efficient rapid extraction and assay method of flavonoids pigment in Chinese rose petal | |
| EP3225615A1 (en) | Preparation method for medicinal chlorogenic acid | |
| CN105566414B (en) | The method that four kinds of flavone glycosides are isolated and purified from waxberry flesh | |
| WO2011080721A2 (en) | A herbal composition as hepatoprotective and treatment for liver disorders | |
| US6867332B1 (en) | Process for producing xanthohumol present in hops and xanthohumol-rich hop extract obtainable thereby | |
| CN101337876A (en) | A method for extracting xanthohumol from hops | |
| CN101781345B (en) | Method for preparing tilianin | |
| CN104829474B (en) | Method for preparing glycine betaine chemical reference substances from boxthorn leaves | |
| CN103172601A (en) | Method for separating and extracting salvianolic acid B | |
| CN111060626B (en) | Origin/variety markers and discriminating methods of Artemisia annua in Xinjiang based on plant metabolomics | |
| Still et al. | Aryl hydroxylation of isopropyl-3-chlorocarbanilate by soybean plants | |
| CN104256640A (en) | Method for extracting natural antioxidant substances from naseberry leaves | |
| KR102240357B1 (en) | Antioxidant composition for cosmetics containing a compound isolated from extract of Rosa rugosa Thumb | |
| CN111257438B (en) | Enrichment and characterization method of American ginseng polypeptide | |
| EP4595947A1 (en) | Preparation method for polyporus umbellatus soup, polyporus umbellatus extractum, and solid formulation of polyporus umbellatus | |
| Statz et al. | Preparation of Plant Extracts for Antitumor Screening¹ | |
| CN114133401A (en) | Preparation method of dictamnine monomer | |
| CN108037207A (en) | A kind of UPLC-MS-MS rapid screenings Artemisia capillaris and the method for artemisia scoparia difference base source otherness | |
| CN110511200A (en) | A method of Hopeaphenol or/and Isohopeaphenol is separated from Chinese small iris | |
| Brazdovlcova et al. | Isolation and identification of alkaloids from fruits of Berberis thunbergii DC |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: GOVERNMENT OF MALAYSIA AS REPRESENTED BY THE MINIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YUSOFF, MASHITAH MOHD.;WAN MOHAMUD, WAN NAZAIMOON;SIGNING DATES FROM 20060310 TO 20100310;REEL/FRAME:024112/0605 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |